5A2-SC8
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
CP-LC-1074 is a homocysteine-derived ionizable cationic lipid that enables highly efficient in vivo delivery of various RNA therapeutics (including mRNA, cRNA, and saRNA) with robust protein expression. When formulated in standard LNP compositions (50:38.5:10:1.5 molar ratio of ionizable lipid:cholesterol:DOPE:PEG-lipid), it demonstrates superior lung-specific targeting compared to commercial alternatives following intravenous administration, while maintaining an excellent safety profile.
| CAS No. | Not available |
| Chemical Name | CP-LC-1074 |
| Synonyms | CPLC1074,CP LC 1074 |
| SMILES | O=C(NCCN(C)C)C(CCSCCC(OCCCCCCCCCCCCCCCC)=O)NC(CCCCC(CCSCCC(OCCCCCCCC)=O)SCCC(OCCCCCCCC)=O)=O |
| Formula | C57H109N3O8S3 |
| M.Wt | 1,060.7 |
| Purity | >98% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 9.4277 mL | 1.8855 mL | 942.77 μL |
| 25 mg | 23.5693 mL | 4.7139 mL | 2.3569 mL |
| 50 mg | 47.1387 mL | 9.4277 mL | 4.7139 mL |
| 100 mg | 94.2774 mL | 18.8555 mL | 9.4277 mL |
| 250 mg | 235.6934 mL | 47.1387 mL | 23.5693 mL |
Contact our team with the catalog number and requested quantity.